Psychedelic Lobbying and Regulatory Capture
Not all lobbying campaigns are problematic — the goal should be for regulators to leverage industry insights while maintaining independence in decision-making.
psychedelic therapies
-
Read more: Psychedelic Lobbying and Regulatory Capture -
Read more: What Counts as a Psychedelic? What Counts as a Psychedelic?
There is little consensus in defining “psychedelic.” Yet, research on and access to these substances hinges on what gets included under this umbrella.
-
Read more: Ketamine Is the New Viagra Ketamine Is the New Viagra
A combination of high demand and a patent monopoly has created a perfect storm of profitability for Janssen’s Spravato.
-
Read more: Is Microdosing Just Placebo? Is Microdosing Just Placebo?
People who microdose psychedelics claim that it provides a very wide range of benefits. Is it just a placebo effect?
-
Read more: Introducing Affiliated Researchers for the Project on Psychedelics Law and Regulation Introducing Affiliated Researchers for the Project on Psychedelics Law and Regulation
We are excited to welcome our inaugural group of affiliated researchers for the Project on Psychedelics Law and Regulation (POPLAR).
-
Read more: What Macrodosing Can Learn from Microdosing What Macrodosing Can Learn from Microdosing
While standard doses of psychedelics will ostensibly be higher than a microdose, the question of just how much higher should be the topic of debate.
-
Read more: A Precise Definition of Microdosing Psychedelics is Needed to Promote Equitable Regulation A Precise Definition of Microdosing Psychedelics is Needed to Promote Equitable Regulation
A mutual understanding of the term “microdosing psychedelics” is needed to conduct accurate research, promote regulations, and educate the wider population.
-
Read more: The Myth of Psychedelic Exceptionalism The Myth of Psychedelic Exceptionalism
Psychedelic drug reform is not occurring at the expense of other drug reforms. Instead, it paves the way for larger reforms.
-
Read more: The Cost of Exclusion in Psychedelic Research The Cost of Exclusion in Psychedelic Research
The lack of diversity among research participants can have significant consequences on generalizability and distribution of treatments.
-
Read more: What Psychedelic Research Can Learn from Science, and What It Can Teach What Psychedelic Research Can Learn from Science, and What It Can Teach
The field has a frustrating tendency to make lofty claims about psychedelics that stray from the realities and limitations of the data.
